Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system

Archives of Internal Medicine

Volumn 164, Issue 16, 2004, Pages 1807-1811

  García Vázquez, Elisa ^a   Marcos, María Angeles ^a   Mensa, José ^a   De Roux, Andrés ^a   Puig, Jordi ^a   Font, Carmen ^a   Francisco, Gloria ^a   Torres, Antonio ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM IDENTIFICATION; COMMUNITY ACQUIRED PNEUMONIA; DIAGNOSTIC VALUE; FEMALE; GRAM POSITIVE COCCI; GRAM POSITIVE DIPLOCOCCI; GRAM STAINING; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MICROORGANISM; MORPHOLOGY; PATIENTS OUTCOME RESEARCH TEAM PREDICTIVE SCORING SYSTEM; PREDOMINANT MORPHOTYPE; PRIORITY JOURNAL; SAMPLING; SCORING SYSTEM; SPUTUM CULTURE; SPUTUM QUALITY; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; COHORT STUDIES; COLONY COUNT, MICROBIAL; COMMUNITY-ACQUIRED INFECTIONS; COUGH; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA; SENSITIVITY AND SPECIFICITY; SPUTUM;

EID: 4544295369     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.16.1807     Document Type: Article

References (38)

1. Holmberg H, Bodin L, Jonsson I, Krook A. Rapid aetiological diagnosis of pneumonia based on routine laboratory features. Scand J Infect Dis. 1990;22:537-545.
2. Sopena N, Sabrià-Leal M, Pedro-Botet ML, et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest. 1998;113:1195-1200.
3. Woodhead MA, McFarlane JT. Comparative clinical and laboratory features of Legionella with pneumococcal and Mycoplasma pneumonias. Br J Dis Chest. 1987; 81:133-139.
4. San Pedro GS, Campbell GD Jr. Limitations of diagnostic testing in the initial management of patients with community-acquired pneumonia. Semin Respir Infect. 1997;12:300-307.
5. Gleckman R, DeVita J, Hibert D, Pelletier C, Martín R. Sputum gram stain assessment in community-acquired pneumonia. J Clin Microbiol. 1988;26:846-849.
6. Fine MJ, Orloff JJ, Rihs JD, et al. Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med. 1991;6:189-198.
7. Roson B, Carratala J, Verdaguer R, Dorca J, Manresa F, Gudiol F. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis. 2000;31:347-382.
8. Ewig S, Schlochtermeier M, Göke N, Niederman M. Applying sputum as a diagnostic tool in pneumonia. Chest. 2002;121:1486-1492:
9. Cordero E, Pachón J, Rivero A, et al. Usefulness of sputum culture for diagnosis of bacterial pneumonia in HIV infected patients. Eur J Clin Microbiol Infect Dis. 2002;21:362-367.
10. Belliveau P, Hickingbotham N, Maderazo EG, Mazens-Sullivan M, Robinson A. Institution-specific patterns of infection and Gram's stain as guides for empiric treatment of patients hospitalized with typical community-acquired pneumonia. Pharmacotherapy. 1993;13:396-401.
11. Bohte R, Hermans J, van den Broek PJ. Early recognition of Streptococcus pneumoniae in patients with community acquired pneumonia. Eur J Clin Microbiol Infect Dis. 1996;15:201-205.
12. Bartlett JG, Dowell SF, Mandell LA, File TM, Musher DM, Fine JM. Practice guidelines for the management of community-acquired pneumonia in adults: guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2000;31: 347-382.
13. Niederman MS, Bass JB Jr, Campbell GD; American Thoracic Society and the Medical Section of the American Lung Association. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993;148: 1418-1426.
14. Niederman MS, Mandell LA, Anzueto A; American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-1754.
15. Waterer GW, Wunderink RG. The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures. Respir Med. 2001;95: 78-82.
16. Chalasani NP, Valdecanas MA, Gopal AK, McGowan JE Jr, Jurado RL. Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks. Chest. 1995;108:932-936.
17. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community acquired pneumonia. N Engl J Med. 1997;336:243-250.
18. Ruiz M, Ewig S, Marcos MA, et al. Aetiology of community-acquired pneumonia: impact of age, comorbidity and severity. Am J Respir Crit Care Med. 1999; 160:397-405.
19. García Vázquez E, Martínez JA, Mensa J, et al. Reactive protein levels in community acquired pneumonia. Eur Respir J. 2003;21:702-705.
20. Plouffe JF, McNally C, File TM Jr. Value of noninvasive studies in community-acquired pneumonia. Infect Dis Clin North Am. 1998;12:689-699.
21. Bandyopadhyay T, Gerardi DA, Metersky ML. A comparison of induced and expectorated sputum for the microbiological diagnosis of community acquired pneumonia Respiration. 2000;67:173-176.
22. Rein MF, Gwaltney JM, O'Brien WM, et al. Accuracy of Gram's stain in identifying pneumococci in sputum. JAMA. 1978;239:2671-2673.
23. Boerner DF, Zwadyk P. The value of the sputum Gram's stain in community-acquired pneumonia. JAMA. 1982;247:642-645.
24. Gleckman R, DeVita J, Hibert D, et al. Sputum Gram stain assessment in community-acquired bacteremic pneumonia. J Clin Microbiol. 1988;26:846-849.
25. Levy M, Dromer F, Brion L, Leturdu F, Carbon C. Community-acquired pneumonia: importance of initial noninvasive bacteriologic and radiographic investigations. Chest. 1988;93:43-48.
26. Perlino CA. Laboratory diagnosis of pneumonia due to Streptococcus pneumoniae. J Infect Dis. 1984;150:139-144.
27. McDonald KS, Scriver SR, Low DE. Community-acquired pneumonia: the future of the microbiology laboratory; focused diagnosis or syndromic management? Semin Respir Infect. 1994;9:180-188.
28. Theerthakarai R, El-Halees W, Ismail M, Solis RA, Khan MA. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia. Chest. 2001;119:181-184.
29. Ewig S, Bauer T, Hasputumer E, et al. Value of routine microbial investigation in community-acquired pneumonia treated in tertiary care centre. Respiration. 1996; 63:164-169.
30. Woodhead MA, Arrowsmith J, Chamberlain-Webber R, Wooding S, Williams I. The value of routine microbial investigation in community-acquired pneumonia. Respir Med. 1991;85:313-317.
31. Lentino JR, Lucks DA. Non value of sputum culture in the management of lower respiratory tract infections. J Clin Microbiol. 1987;25:758-762.
32. Fine MJ, Orloff JJ, Rihs JD, et al. Evaluation of housestaff physicians' preparation and interpretation of sputum Gram stains for community-acquired pneumonia. J Gen Intern Med. 1991;6:189-198.
33. Redd WW, Byrd GS, Gates RH Jr, et al. Sputum Gram's stain in community-acquired pneumococcal pneumonia: a metaanalysis. West J Med. 1996;165: 197-204.
34. Gleason PP, Meehan TP, Fine JM, et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med. 1999;159:2562-2572.
35. Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 1999;159:2576-2580.
36. Martinez JA, Horcajada JP, Almela M, et al. Addition of a macrolide to a beta-lactam based empirical antibiotic regimen is associated with lower in hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2003;36:389-395.
37. Lawrence SJ, Shadel BN, Leet TL, Hall JB, Mundy LM. An intervention to improve antibiotic delivery and sputum procurement in patients hospitalized with CAP. Chest. 2002;122:913-919.
38. Sanyal S, Smith PR, Saha AC, et al. Initial microbiological studies did not affect outcome in adults hospitalized with community-acquired pneumonia. Am J Respir Crit Care Med. 1999;160:346-348.